AMGN
Price
$300.07
Change
-$1.30 (-0.43%)
Updated
Jul 31, 01:10 PM (EDT)
Capitalization
151.69B
5 days until earnings call
MRK
Price
$78.53
Change
-$3.22 (-3.94%)
Updated
Jul 31, 03:19 PM (EDT)
Capitalization
331.75B
91 days until earnings call
Interact to see
Advertisement

AMGN vs MRK

Header iconAMGN vs MRK Comparison
Open Charts AMGN vs MRKBanner chart's image
Amgen
Price$300.07
Change-$1.30 (-0.43%)
Volume$200
Capitalization151.69B
Merck & Co
Price$78.53
Change-$3.22 (-3.94%)
Volume$13.98K
Capitalization331.75B
AMGN vs MRK Comparison Chart in %
Loading...
AMGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MRK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AMGN vs. MRK commentary
Jul 31, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AMGN is a Buy and MRK is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 31, 2025
Stock price -- (AMGN: $301.37 vs. MRK: $81.75)
Brand notoriety: AMGN and MRK are both notable
Both companies represent the Pharmaceuticals: Major industry
Current volume relative to the 65-day Moving Average: AMGN: 65% vs. MRK: 90%
Market capitalization -- AMGN: $151.69B vs. MRK: $331.75B
AMGN [@Pharmaceuticals: Major] is valued at $151.69B. MRK’s [@Pharmaceuticals: Major] market capitalization is $331.75B. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $739.66B to $0. The average market capitalization across the [@Pharmaceuticals: Major] industry is $86.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AMGN’s FA Score shows that 2 FA rating(s) are green whileMRK’s FA Score has 2 green FA rating(s).

  • AMGN’s FA Score: 2 green, 3 red.
  • MRK’s FA Score: 2 green, 3 red.
According to our system of comparison, AMGN is a better buy in the long-term than MRK.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AMGN’s TA Score shows that 6 TA indicator(s) are bullish while MRK’s TA Score has 2 bullish TA indicator(s).

  • AMGN’s TA Score: 6 bullish, 4 bearish.
  • MRK’s TA Score: 2 bullish, 5 bearish.
According to our system of comparison, AMGN is a better buy in the short-term than MRK.

Price Growth

AMGN (@Pharmaceuticals: Major) experienced а -2.54% price change this week, while MRK (@Pharmaceuticals: Major) price change was -2.66% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was +2.31%. For the same industry, the average monthly price growth was +7.58%, and the average quarterly price growth was +14.63%.

Reported Earning Dates

AMGN is expected to report earnings on Oct 29, 2025.

MRK is expected to report earnings on Oct 30, 2025.

Industries' Descriptions

@Pharmaceuticals: Major (+2.31% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MRK($332B) has a higher market cap than AMGN($152B). MRK has higher P/E ratio than AMGN: MRK (935.64) vs AMGN (22.66). AMGN YTD gains are higher at: 18.199 vs. MRK (-16.283). AMGN has higher annual earnings (EBITDA): 14.8B vs. MRK (6.91B). AMGN has more cash in the bank: 10.9B vs. MRK (7.09B). MRK has less debt than AMGN: MRK (35.1B) vs AMGN (64.6B). MRK has higher revenues than AMGN: MRK (60.1B) vs AMGN (28.2B).
AMGNMRKAMGN / MRK
Capitalization152B332B46%
EBITDA14.8B6.91B214%
Gain YTD18.199-16.283-112%
P/E Ratio22.66935.642%
Revenue28.2B60.1B47%
Total Cash10.9B7.09B154%
Total Debt64.6B35.1B184%
FUNDAMENTALS RATINGS
AMGN vs MRK: Fundamental Ratings
AMGN
MRK
OUTLOOK RATING
1..100
7576
VALUATION
overvalued / fair valued / undervalued
1..100
23
Undervalued
12
Undervalued
PROFIT vs RISK RATING
1..100
3974
SMR RATING
1..100
1324
PRICE GROWTH RATING
1..100
5062
P/E GROWTH RATING
1..100
9191
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

MRK's Valuation (12) in the Pharmaceuticals Major industry is in the same range as AMGN (23) in the Biotechnology industry. This means that MRK’s stock grew similarly to AMGN’s over the last 12 months.

AMGN's Profit vs Risk Rating (39) in the Biotechnology industry is somewhat better than the same rating for MRK (74) in the Pharmaceuticals Major industry. This means that AMGN’s stock grew somewhat faster than MRK’s over the last 12 months.

AMGN's SMR Rating (13) in the Biotechnology industry is in the same range as MRK (24) in the Pharmaceuticals Major industry. This means that AMGN’s stock grew similarly to MRK’s over the last 12 months.

AMGN's Price Growth Rating (50) in the Biotechnology industry is in the same range as MRK (62) in the Pharmaceuticals Major industry. This means that AMGN’s stock grew similarly to MRK’s over the last 12 months.

AMGN's P/E Growth Rating (91) in the Biotechnology industry is in the same range as MRK (91) in the Pharmaceuticals Major industry. This means that AMGN’s stock grew similarly to MRK’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AMGNMRK
RSI
ODDS (%)
Bullish Trend 7 days ago
70%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
48%
Bearish Trend 2 days ago
55%
Momentum
ODDS (%)
Bullish Trend 2 days ago
51%
Bearish Trend 2 days ago
54%
MACD
ODDS (%)
Bearish Trend 2 days ago
57%
Bearish Trend 2 days ago
52%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
54%
Bearish Trend 2 days ago
50%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
56%
Bullish Trend 2 days ago
45%
Advances
ODDS (%)
Bullish Trend 9 days ago
56%
Bullish Trend 7 days ago
48%
Declines
ODDS (%)
Bearish Trend 4 days ago
52%
Bearish Trend 3 days ago
51%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
49%
Bearish Trend 2 days ago
52%
Aroon
ODDS (%)
Bullish Trend 2 days ago
50%
Bullish Trend 2 days ago
57%
View a ticker or compare two or three
Interact to see
Advertisement
AMGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MRK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
SAMT35.510.36
+1.04%
Strategas Macro Thematic Opp ETF
JHHY25.77N/A
N/A
JHancock High Yield ETF
DBA25.96-0.05
-0.19%
Invesco DB Agriculture
HYG80.33-0.17
-0.21%
iShares iBoxx $ High Yield Corp Bd ETF
NDIA29.18-0.36
-1.22%
Global X India Active ETF

AMGN and

Correlation & Price change

A.I.dvisor indicates that over the last year, AMGN has been loosely correlated with PFE. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if AMGN jumps, then PFE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AMGN
1D Price
Change %
AMGN100%
-0.72%
PFE - AMGN
59%
Loosely correlated
-2.02%
GSK - AMGN
52%
Loosely correlated
+3.45%
ABBV - AMGN
50%
Loosely correlated
-1.00%
GILD - AMGN
49%
Loosely correlated
+0.46%
NVS - AMGN
48%
Loosely correlated
+0.39%
More

MRK and

Correlation & Price change

A.I.dvisor indicates that over the last year, MRK has been loosely correlated with PFE. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if MRK jumps, then PFE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MRK
1D Price
Change %
MRK100%
-2.75%
PFE - MRK
49%
Loosely correlated
-2.02%
BIIB - MRK
46%
Loosely correlated
-0.99%
ABBV - MRK
43%
Loosely correlated
-1.00%
AZN - MRK
43%
Loosely correlated
+3.53%
AMGN - MRK
42%
Loosely correlated
-0.72%
More